Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Temporal Dynamics of Multiple Sclerosis Risk: Integrating Genetic Susceptibility and Early-Life Exposures
Genetics
Temporal Dynamics of Multiple Sclerosis Risk: Integrating Genetic Susceptibility and Early-Life Exposures

19, Mar 2026

2
Temporal Dynamics of Multiple Sclerosis Risk: Integrating Genetic Susceptibility and Early-Life Exposures
Genetics
Decoding Biological Complexity: An Integrative Analysis of Molecular Systems

17, Mar 2026

3
Decoding the Genetic Architecture of Multiple Sclerosis: From Disease Susceptibility to Clinical Severity
Genetics
Decoding the Genetic Architecture of Multiple Sclerosis: From Disease Susceptibility to Clinical Severity

17, Mar 2026

4
Genetic and Gene Expression Signatures in Multiple Sclerosis: Insights from Modern Genomic Research
Genetics
Genetic and Gene Expression Signatures in Multiple Sclerosis: Insights from Modern Genomic Research

16, Mar 2026

5
Polygenic Risk Scores Reveal Genetic Stratification of Lifetime Multiple Sclerosis Risk
Genetics
Polygenic Risk Scores Reveal Genetic Stratification of Lifetime Multiple Sclerosis Risk

15, Mar 2026

Categories:
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis

25, Aug 2025

Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis

25, Aug 2025

Ocrelizumab and the Role of NK Cells in Multiple Sclerosis
Genetics
Ocrelizumab and the Role of NK Cells in Multiple Sclerosis

27, Aug 2025

Multiple Sclerosis: CHIT1 and SERPINA3 as Candidate CSF Biomarkers of Progressive Biology
Genetics
Multiple Sclerosis: CHIT1 and SERPINA3 as Candidate CSF Biomarkers of Progressive Biology

28, Aug 2025